Pharmacokinetics of colistin in a 8-year-old child with acute bone infection.
暂无分享,去创建一个
W. Couet | É. Senneville | E. Nectoux | N. Grégoire | C. Loiez | D. Fron | S. Marchand | S. Magréault | C. Petyt
[1] R. Nation. Dose Suggestions for Intravenous Colistin in Pediatric Patients: Caution Required. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] W. Couet,et al. Clinical Pharmacokinetics and Pharmacodynamics of Colistin , 2017, Clinical Pharmacokinetics.
[3] J. N. van den Anker,et al. Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children , 2015, Clinical Pharmacokinetics.
[4] Brian T. Tsuji,et al. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. , 2015, The Lancet. Infectious diseases.
[5] W. Couet,et al. Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80‐mg Intravenous Dose of CMS in Young Healthy Volunteers , 2011, Clinical pharmacology and therapeutics.